Status:
COMPLETED
Assessment Of Safety And Efficacy Of SU11248 In Patients With Metastatic Colorectal Cancer Who Have Failed Selected Previous Treatments.
Lead Sponsor:
Pfizer
Conditions:
Colorectal Neoplasms
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Assessment of safety and efficacy of SU11248 in patients with metastatic colorectal cancer who have failed selected previous treatments.
Eligibility Criteria
Inclusion
- Metastatic colorectal cancer
- Failed selected cancer therapies in the past.
Exclusion
- Prior treatment with tyrosine kinase inhibitors or VEGF inhibitors other than bevacizumab.
Key Trial Info
Start Date :
December 1 2003
Trial Type :
INTERVENTIONAL
End Date :
April 1 2005
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT00077987
Start Date
December 1 2003
End Date
April 1 2005
Last Update
January 11 2007
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.